Aquestive Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SCHOBEL ALEXANDER MARK officer: Chief Innovation/Tech ..
 Common Stock 1,000 $10.25 $10,250
Purchase
KENDALL KEITH J director, officer: CEO and Pres..
 Common Stock 6,000 $10.17 $61,020
Option
SCHOBEL ALEXANDER MARK officer: Chief Innovation/Tech ..
 Common Stock 329 N/A N/A
Option
SCHOBEL ALEXANDER MARK officer: Chief Innovation/Tech ..
 Restricted Stock Unit 329 N/A N/A
Option
KENDALL KEITH J director, officer: CEO and Pres..
 Restricted Stock Unit 329 N/A N/A
Option
KENDALL KEITH J director, officer: CEO and Pres..
 Common Stock 329 N/A N/A
Option
SCHOBEL ALEXANDER MARK officer: Chief Innovation/Tech ..
 Restricted Stock Unit 14,572 N/A N/A
Option
SCHOBEL ALEXANDER MARK officer: Chief Innovation/Tech ..
 Common Stock 14,572 N/A N/A
Option
KENDALL KEITH J director, officer: CEO and Pres..
 Restricted Stock Unit 14,572 N/A N/A
Option
KENDALL KEITH J director, officer: CEO and Pres..
 Common Stock 14,572 N/A N/A
Purchase
BRATTON DOUGLAS K director, 10 percent owner
 Common Stock 165,000 $15 $2,475,000

Showing 100 to 111 of 111 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: